Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development. [electronic resource] by
- Halpern, Wendy G
- Ameri, Mehrdad
- Bowman, Christopher J
- Elwell, Michael R
- Mirsky, Michael L
- Oliver, Julian
- Regan, Karen S
- Remick, Amera K
- Sutherland, Vicki L
- Thompson, Kary E
- Tremblay, Claudine
- Yoshida, Midori
- Tomlinson, Lindsay
Producer: 20171201
In:
Toxicologic pathology vol. 44
Availability: No items available.
|